Activist calls foul over Unilabs

French hedge fund manager Fincapital has slammed the chairman of Unilabs, claiming the Swiss laboratory services company's takeover by a rival favours him at the expense of minority shareholders.

Unilabs yesterday agreed a takeover from Swedish rival Capio Diagnostics, owned by buyout firms Apax and Nordic Capital, that would value the company at Sfr700m (€420m), a premium of almost a third to its recent trading price.

WSJ Logo
Pro Bono or Pro Nono? Law Firms Split on Fulfilling Deals With TrumpExternal link

Pro Bono or Pro Nono? Law Firms Split on Fulfilling Deals With Trump